Advances in drug development. BRAF validation in melanoma

Clin Adv Hematol Oncol. 2010 Jan;8(1):31-4.
No abstract available

MeSH terms

  • Humans
  • Melanoma / drug therapy
  • Melanoma / genetics*
  • Mutation*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf / genetics*

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf